Renaissance Technologies’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$691K Buy
2,095,309
+1,071,509
+105% +$353K ﹤0.01% 2678
2025
Q1
$319K Buy
1,023,800
+916,100
+851% +$286K ﹤0.01% 2911
2024
Q4
$101K Buy
107,700
+63,200
+142% +$59K ﹤0.01% 3285
2024
Q3
$52.5K Sell
44,500
-96,700
-68% -$114K ﹤0.01% 3337
2024
Q2
$109K Sell
141,200
-15,600
-10% -$12K ﹤0.01% 3168
2024
Q1
$478K Buy
156,800
+105,600
+206% +$322K ﹤0.01% 2884
2023
Q4
$165K Sell
51,200
-29,600
-37% -$95.4K ﹤0.01% 3191
2023
Q3
$310K Sell
80,800
-33,900
-30% -$130K ﹤0.01% 2918
2023
Q2
$376K Sell
114,700
-5,900
-5% -$19.3K ﹤0.01% 3022
2023
Q1
$311K Buy
120,600
+800
+0.7% +$2.06K ﹤0.01% 3103
2022
Q4
$223K Buy
119,800
+1,000
+0.8% +$1.86K ﹤0.01% 3368
2022
Q3
$219K Sell
118,800
-5,000
-4% -$9.22K ﹤0.01% 3350
2022
Q2
$266K Buy
123,800
+39,000
+46% +$83.8K ﹤0.01% 3521
2022
Q1
$266K Buy
84,800
+26,200
+45% +$82.2K ﹤0.01% 3525
2021
Q4
$188K Buy
58,600
+24,100
+70% +$77.3K ﹤0.01% 3531
2021
Q3
$116K Buy
+34,500
New +$116K ﹤0.01% 3296
2021
Q1
Sell
-710,507
Closed -$1.64M 3601
2020
Q4
$1.64M Buy
+710,507
New +$1.64M ﹤0.01% 2244
2020
Q3
Sell
-624,109
Closed -$4.6M 3595
2020
Q2
$4.6M Sell
624,109
-228,734
-27% -$1.69M ﹤0.01% 1695
2020
Q1
$2.54M Sell
852,843
-231,866
-21% -$691K ﹤0.01% 1936
2019
Q4
$4.5M Buy
1,084,709
+497,984
+85% +$2.07M ﹤0.01% 1914
2019
Q3
$1.9M Buy
586,725
+115,116
+24% +$373K ﹤0.01% 2307
2019
Q2
$872K Buy
471,609
+108,392
+30% +$200K ﹤0.01% 2743
2019
Q1
$643K Buy
363,217
+308,117
+559% +$545K ﹤0.01% 2848
2018
Q4
$133K Buy
+55,100
New +$133K ﹤0.01% 3196